Journal publications

• Skulberg, Arne Kristian; Tylleskär, Ida; Valberg, Morten; Braarud, Anne-Cathrine; Dale, Jostein; Heyerdahl, Fridtjof; Skålhegg, Tore; Barstein, Jan; Mellesmo, Sindre; Dale, Ola. (2022) Comparison of intranasal and intramuscular naloxone in opioid overdoses managed by ambulance staff: a double-dummy, randomised, controlled trial. Addiction.
• Borchgrevink, Petter Chr.; Glette, Mari; Woodhouse, Astrid; Butler, Stephen; Landmark, Tormod; Romundstad, Pål; Dale, Ola; Stiles, Tore C; Bønaa, Kaare H.; Thorsvik, Dagfinn; Thünte, Sabina; Kaasa, Stein. (2021) A Clinical Description of Chronic Pain in a General Population Using ICD-10 and ICD-11 (The HUNT Pain Examination Study). Journal of Pain. vol. 23 (2).
• Tylleskär, Ida; Skarra, Sissel; Skulberg, Arne Kristian; Dale, Ola. (2021) The pharmacokinetic interaction between nasally administered naloxone and the opioid remifentanil in human volunteers. European Journal of Clinical Pharmacology.
• Skulberg, Arne Kristian; Tylleskär, Ida; Næss, Anne-Cathrine Braarud; Dale, Jostein; Heyerdahl, Fridtjof; Mellesmo, Sindre; Valberg, Morten; Dale, Ola. (2020) NTNU intranasal naloxone trial (NINA-1) study protocol for a double-blind, double-dummy, non-inferiority randomised controlled trial comparing intranasal 1.4 mg to intramuscular 0.8 mg naloxone for prehospital use. BMJ Open. vol. 10:e041556 (11).
• Tylleskär, Ida; Gjersing, Linn; Bjørnsen, Lars Petter Bache-Wiig; Braarud, Anne-Cathrine; Heyerdahl, Fridtjof; Dale, Ola; Skulberg, Arne Kristian. (2020) Prehospital naloxone administration – what influences choice of dose and route of administration?. BMC Emergency Medicine. vol. 20.
• Magnin, Anette; Iversen, Valentina Cabral; Calvo, Gonzalo; Cecetkova, Beata; Dale, Ola; Demlova, Regina; Blasko, George; Keane, Fionnuala; Kovács, Gabor G.; Levy-Marchal, Claire; Monteiro, Emilia; Palmisano, Lucia; Pella, Daniel; Portoles, Antonio; Rascol, Olivier; Schmied, Caecilia; Tay, Fabian; von der Leyen, Heiko; Ohmann, Christian. (2019) European survey on national training activities in clinical research. Trials. vol. 20.
• Skulberg, Arne Kristian; Åsberg, Anders; Zare, Hasse Khiabani; Røstad, Hilde; Tylleskär, Ida; Dale, Ola. (2019) Pharmacokinetics of a novel, approved, 1.4-mg intranasal naloxone formulation for reversal of opioid overdose—a randomized controlled trial. Addiction. vol. 114 (5).
• Strang, John; McDonald, Rebecca; Campbell, Gabrielle; Degenhardt, Louisa; Nielsen, Suzanne; Ritter, Alison; Dale, Ola. (2019) Take-home naloxone for the emergency interim management of opioid overdose: The public health application of an emergency medicine. Drugs.
• Tylleskär, Ida; Skulberg, Arne Kristian; Nilsen, Turid; Skarra, Sissel; Dale, Ola. (2019) Naloksonnesespray – biotilgjengelighet og opptaksmønster i en fase 1-studie. Tidsskrift for Den norske legeforening. vol. 139 (13).
• Landmark, Tormod; Dale, Ola; Romundstad, Pål Richard; Woodhouse, Astrid; Kaasa, Stein; Borchgrevink, Petter Chr.. (2018) Development and course of chronic pain over 4 years in the general population: The HUNT pain study. European Journal of Pain. vol. 22 (9).
• Madah-Amiri, Desiree; Skulberg, Arne Kristian; Næss, Anne-Cathrine Braarud; Dale, Ola; Heyerdahl, Fridtjof; Lobmaier, Philipp Paul; Clausen, Thomas. (2018) Ambulance-attended opioid overdoses: An examination into overdose locations and the role of a safe injection facility. Substance Abuse.
• Skulberg, Arne Kristian; Tylleskär, Ida; Nilsen, Turid; Skarra, Sissel; Salvesen, Øyvind; Sand, Trond; Loftsson, Thorsteinn; Dale, Ola. (2018) Pharmacokinetics and -dynamics of intramuscular and intranasal naloxone: an explorative study in healthy volunteers. European Journal of Clinical Pharmacology. vol. 74 (7).
• Tylleskär, Ida; Skulberg, Arne Kristian; Skarra, Sissel; Nilsen, Turid; Dale, Ola. (2018) Pharmacodynamics and arteriovenous difference of intravenous naloxone in healthy volunteers exposed to remifentanil. European Journal of Clinical Pharmacology. vol. 74 (12).
• McDonald, Rebecca; Glende, Øyvind Danielsson; Dale, Ola; Strang, John. (2017) International patent applications for non-injectable naloxone for opioid overdose reversal: Exploratory search and retrieve analysis of the PatentScope database. Drug and Alcohol Review. vol. 37 (2).
• Skulberg, Arne Kristian; Dale, Ola; Tylleskär, Ida. (2017) Opioid education programs and nasal naloxone rescue kits in Europe. Toxicology Letters. vol. 280.
• Tylleskär, Ida; Skulberg, Arne Kristian; Nilsen, Turid; Skarra, Sissel; Jansook, Phatsawee; Dale, Ola. (2017) Pharmacokinetics of a new, nasal formulation of naloxone. European Journal of Clinical Pharmacology. vol. 73 (5).
• Dale, Ola. (2016) Ethical issues and stakeholders matter. Addiction. vol. 111 (4).
• Skorpen, Frank; von Hofacker, Sebastian; Bjørngaard, Mads; Skogholt, Anne Heidi; Dale, Ola; Kaasa, Stein; Klepstad, Pål. (2016) The rare Arg181Cys mutation in the μ opioid receptor can abolish opioid responses. Acta Anaesthesiologica Scandinavica. vol. 60 (8).
• Barratt, Daniel T.; Klepstad, Pål; Dale, Ola; Kaasa, Stein; Somogyi, Andrew A.. (2015) Innate immune signalling genetics of pain, cognitive dysfunction and sickness symptoms in cancer pain patients treated with transdermal fentanyl. PLOS ONE. vol. 10:0137179 (9).
• Dale, Ola; Borchgrevink, Petter Chr.; Fredheim, Olav Magnus; Mahic, Milada; Romundstad, Pål Richard; Skurtveit, Svetlana. (2015) Prevalence of use of non-prescription analgesics in the Norwegian HUNT3 population: Impact of gender, age, exercise and prescription of opioids. BMC Public Health. vol. 15.